Skip to main content
NCBI home page
Gut logoLink to Gut
. 2002 Jul;51(Suppl 1):i87–i90. doi: 10.1136/gut.51.suppl_1.i87

Pharmacotherapy: non-serotonergic mechanisms

R Spiller
PMCID: PMC1867722  PMID: 12077075

Full Text

The Full Text of this article is available as a PDF (115.0 KB).

Figure 1 .

Figure 1

Open in a new tab

Results of a three month clinical trial of loperamide compared with placebo. The dose was titrated to best effect and ranged from 2 to 8 mg per day. *p<0.05, **p<0.01. Reproduced with permission from Lavo and colleagues.14

Figure 2 .

Figure 2

Open in a new tab

Octreotide 100 µg subcutaneously increased rectal compliance in eight patients with symptoms of diarrhoea compared with placebo. Reproduced with permission from Hasler and colleagues.23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumer P., Danays T., Lion L., Cosnes J., Gendre J. P., Le Quintrec Y. Effet de la clonidine sur le temps de transit oro-caecal chez l'homme sain. Ann Gastroenterol Hepatol (Paris) 1989 Jan-Feb;25(1):5–9. [PubMed] [Google Scholar]
  2. Bearcroft C. P., Perrett D., Farthing M. J. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut. 1998 Jan;42(1):42–46. doi: 10.1136/gut.42.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bernstein C. N., Niazi N., Robert M., Mertz H., Kodner A., Munakata J., Naliboff B., Mayer E. A. Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain. 1996 Aug;66(2-3):151–161. doi: 10.1016/0304-3959(96)03062-x. [DOI] [PubMed] [Google Scholar]
  4. Bharucha A. E., Camilleri M., Zinsmeister A. R., Hanson R. B. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol. 1997 Nov;273(5 Pt 1):G997–1006. doi: 10.1152/ajpgi.1997.273.5.G997. [DOI] [PubMed] [Google Scholar]
  5. Bonnet F., Boico O., Rostaing S., Saada M., Loriferne J. F., Touboul C., Abhay K., Ghignone M. Postoperative analgesia with extradural clonidine. Br J Anaesth. 1989 Oct;63(4):465–469. doi: 10.1093/bja/63.4.465. [DOI] [PubMed] [Google Scholar]
  6. Bradette M., Delvaux M., Staumont G., Fioramonti J., Bueno L., Frexinos J. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone. Dig Dis Sci. 1994 Jun;39(6):1171–1178. doi: 10.1007/BF02093780. [DOI] [PubMed] [Google Scholar]
  7. Bueno L., Fioramonti J., Delvaux M., Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology. 1997 May;112(5):1714–1743. doi: 10.1016/s0016-5085(97)70056-8. [DOI] [PubMed] [Google Scholar]
  8. Buerkle H., Huge V., Wolfgart M., Steinbeck J., Mertes N., Van Aken H., Prien T. Intra-articular clonidine analgesia after knee arthroscopy. Eur J Anaesthesiol. 2000 May;17(5):295–299. doi: 10.1046/j.1365-2346.2000.00659.x. [DOI] [PubMed] [Google Scholar]
  9. Burton M. B., Gebhart G. F. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation. J Pharmacol Exp Ther. 1998 May;285(2):707–715. [PubMed] [Google Scholar]
  10. Cann P. A., Read N. W., Holdsworth C. D., Barends D. Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci. 1984 Mar;29(3):239–247. doi: 10.1007/BF01296258. [DOI] [PubMed] [Google Scholar]
  11. Cann P. A., Rovati L. C., Smart H. L., Spiller R. C., Whorwell P. J. Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome. A pilot multicenter clinical study. Ann N Y Acad Sci. 1994 Mar 23;713:449–450. doi: 10.1111/j.1749-6632.1994.tb44123.x. [DOI] [PubMed] [Google Scholar]
  12. Chey W. D., Beydoun A., Roberts D. J., Hasler W. L., Owyang C. Octreotide reduces perception of rectal electrical stimulation by spinal afferent pathway inhibition. Am J Physiol. 1995 Dec;269(6 Pt 1):G821–G826. doi: 10.1152/ajpgi.1995.269.6.G821. [DOI] [PubMed] [Google Scholar]
  13. Chrubasik J., Meynadier J., Scherpereel P., Wünsch E. The effect of epidural somatostatin on postoperative pain. Anesth Analg. 1985 Nov;64(11):1085–1088. [PubMed] [Google Scholar]
  14. Dapoigny M., Abitbol J. L., Fraitag B. Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study. Dig Dis Sci. 1995 Oct;40(10):2244–2249. doi: 10.1007/BF02209014. [DOI] [PubMed] [Google Scholar]
  15. Edwards C. A., Read N. W. Effect of lidamidine, a proposed alpha 2-adrenoreceptor agonist, on salt and water transport in human jejunum. Dig Dis Sci. 1986 Aug;31(8):817–821. doi: 10.1007/BF01296049. [DOI] [PubMed] [Google Scholar]
  16. Gasbarrini G., Corazza G. R., Feliciani M., Albano O., Stufano N., Altomare E., Fontana G., Valpiani D., Chiodo F., Banterle C. A multicenter double-blind controlled trial comparing lidamidine HCl and loperamide in the symptomatic treatment of acute diarrhoea. Arzneimittelforschung. 1986 Dec;36(12):1843–1845. [PubMed] [Google Scholar]
  17. Gillis R. A., Dias Souza J., Hicks K. A., Mangel A. W., Pagani F. D., Hamilton B. L., Garvey T. Q., 3rd, Pace D. G., Browne R. K., Norman W. P. Inhibitory control of proximal colonic motility by the sympathetic nervous system. Am J Physiol. 1987 Oct;253(4 Pt 1):G531–G539. doi: 10.1152/ajpgi.1987.253.4.G531. [DOI] [PubMed] [Google Scholar]
  18. Gorelick A. B., Koshy S. S., Hooper F. G., Bennett T. C., Chey W. D., Hasler W. L. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol. 1998 Sep;275(3 Pt 1):G460–G466. doi: 10.1152/ajpgi.1998.275.3.G460. [DOI] [PubMed] [Google Scholar]
  19. Gracely R. H., Dubner R., Wolskee P. J., Deeter W. R. Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature. 1983 Nov 17;306(5940):264–265. doi: 10.1038/306264a0. [DOI] [PubMed] [Google Scholar]
  20. Hasler W. L., Soudah H. C., Owyang C. A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention. Gastroenterology. 1993 May;104(5):1390–1397. doi: 10.1016/0016-5085(93)90347-f. [DOI] [PubMed] [Google Scholar]
  21. Hasler W. L., Soudah H. C., Owyang C. Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients. J Pharmacol Exp Ther. 1994 Mar;268(3):1206–1211. [PubMed] [Google Scholar]
  22. Jackson J. L., O'Malley P. G., Tomkins G., Balden E., Santoro J., Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med. 2000 Jan;108(1):65–72. doi: 10.1016/s0002-9343(99)00299-5. [DOI] [PubMed] [Google Scholar]
  23. Jones S. L., Gebhart G. F. Inhibition of spinal nociceptive transmission from the midbrain, pons and medulla in the rat: activation of descending inhibition by morphine, glutamate and electrical stimulation. Brain Res. 1988 Sep 20;460(2):281–296. doi: 10.1016/0006-8993(88)90373-3. [DOI] [PubMed] [Google Scholar]
  24. Kordower J. H., Bodnar R. J. Vasopressin analgesia: specificity of action and non-opioid effects. Peptides. 1984 Jul-Aug;5(4):747–756. doi: 10.1016/0196-9781(84)90017-2. [DOI] [PubMed] [Google Scholar]
  25. Kuraishi Y., Hirota N., Sato Y., Hino Y., Satoh M., Takagi H. Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Res. 1985 Jan 28;325(1-2):294–298. doi: 10.1016/0006-8993(85)90326-9. [DOI] [PubMed] [Google Scholar]
  26. Langlois A., Diop L., Friese N., Pascaud X., Junien J. L., Dahl S. G., Rivière P. J. Fedotozine blocks hypersensitive visceral pain in conscious rats: action at peripheral kappa-opioid receptors. Eur J Pharmacol. 1997 Apr 18;324(2-3):211–217. doi: 10.1016/s0014-2999(97)00089-7. [DOI] [PubMed] [Google Scholar]
  27. Lavö B., Stenstam M., Nielsen A. L. Loperamide in treatment of irritable bowel syndrome--a double-blind placebo controlled study. Scand J Gastroenterol Suppl. 1987;130:77–80. doi: 10.3109/00365528709091003. [DOI] [PubMed] [Google Scholar]
  28. Lawrence J. P., Ishizuka J., Haber B., Townsend C. M., Jr, Thompson J. C. The effect of somatostatin on 5-hydroxytryptamine release from a carcinoid tumor. Surgery. 1990 Dec;108(6):1131–1135. [PubMed] [Google Scholar]
  29. Lembo T., Naliboff B. D., Matin K., Munakata J., Parker R. A., Gracely R. H., Mayer E. A. Irritable bowel syndrome patients show altered sensitivity to exogenous opioids. Pain. 2000 Aug;87(2):137–147. doi: 10.1016/S0304-3959(00)00282-7. [DOI] [PubMed] [Google Scholar]
  30. Louvel D., Delvaux M., Felez A., Fioramonti J., Bueno L., Lazorthes Y., Frexinos J. Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome. Gut. 1996 Nov;39(5):741–747. doi: 10.1136/gut.39.5.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lundeberg T., Meister B., Björkstrand E., Uvnäs-Moberg K. Oxytocin modulates the effects of galanin in carrageenan-induced hyperalgesia in rats. Brain Res. 1993 Apr 16;608(2):181–185. doi: 10.1016/0006-8993(93)91456-3. [DOI] [PubMed] [Google Scholar]
  32. Madrazo I., Franco-Bourland R. E., León-Meza V. M., Mena I. Intraventricular somatostatin-14, arginine vasopressin, and oxytocin: analgesic effect in a patient with intractable cancer pain. Appl Neurophysiol. 1987;50(1-6):427–431. doi: 10.1159/000100753. [DOI] [PubMed] [Google Scholar]
  33. Max M. B., Lynch S. A., Muir J., Shoaf S. E., Smoller B., Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992 May 7;326(19):1250–1256. doi: 10.1056/NEJM199205073261904. [DOI] [PubMed] [Google Scholar]
  34. Meynadier J., Chrubasik J., Dubar M., Wünsch E. Intrathecal somatostatin in terminally ill patients. A report of two cases. Pain. 1985 Sep;23(1):9–12. doi: 10.1016/0304-3959(85)90224-6. [DOI] [PubMed] [Google Scholar]
  35. Morali G. A., Braverman D. Z., Lissi J., Goldstein R., Jacobsohn W. Z. Effect of clonidine on gallbladder contraction and small bowel transit time in insulin-treated diabetics. Am J Gastroenterol. 1991 Aug;86(8):995–999. [PubMed] [Google Scholar]
  36. Neal K. R., Hebden J., Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ. 1997 Mar 15;314(7083):779–782. doi: 10.1136/bmj.314.7083.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Ness T. J., Gebhart G. F. Differential effects of morphine and clonidine on visceral and cutaneous spinal nociceptive transmission in the rat. J Neurophysiol. 1989 Jul;62(1):220–230. doi: 10.1152/jn.1989.62.1.220. [DOI] [PubMed] [Google Scholar]
  38. Ness T. J., Gebhart G. F. Quantitative comparison of inhibition of visceral and cutaneous spinal nociceptive transmission from the midbrain and medulla in the rat. J Neurophysiol. 1987 Oct;58(4):850–865. doi: 10.1152/jn.1987.58.4.850. [DOI] [PubMed] [Google Scholar]
  39. Palmer K. R., Corbett C. L., Holdsworth C. D. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology. 1980 Dec;79(6):1272–1275. [PubMed] [Google Scholar]
  40. Prior A., Wilson K. M., Whorwell P. J. Double-blind study of an alpha 2 agonist in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 1988 Dec;2(6):535–539. doi: 10.1111/j.1365-2036.1988.tb00728.x. [DOI] [PubMed] [Google Scholar]
  41. Przewłocki R., Hassan A. H., Lason W., Epplen C., Herz A., Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience. 1992;48(2):491–500. doi: 10.1016/0306-4522(92)90509-z. [DOI] [PubMed] [Google Scholar]
  42. Rubinoff M. J., Piccione P. R., Holt P. R. Clonidine prolongs human small intestine transit time: use of the lactulose-breath hydrogen test. Am J Gastroenterol. 1989 Apr;84(4):372–374. [PubMed] [Google Scholar]
  43. Sandkühler J., Fu Q. G., Helmchen C. Spinal somatostatin superfusion in vivo affects activity of cat nociceptive dorsal horn neurons: comparison with spinal morphine. Neuroscience. 1990;34(3):565–576. doi: 10.1016/0306-4522(90)90165-z. [DOI] [PubMed] [Google Scholar]
  44. Spiller R. C., Jenkins D., Thornley J. P., Hebden J. M., Wright T., Skinner M., Neal K. R. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000 Dec;47(6):804–811. doi: 10.1136/gut.47.6.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stein C., Hassan A. H., Lehrberger K., Giefing J., Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet. 1993 Aug 7;342(8867):321–324. doi: 10.1016/0140-6736(93)91471-w. [DOI] [PubMed] [Google Scholar]
  46. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med. 1995 Jun 22;332(25):1685–1690. doi: 10.1056/NEJM199506223322506. [DOI] [PubMed] [Google Scholar]
  47. Talley N. J., Turner I., Middleton W. R. Somatostatin and symptomatic relief of irritable bowel syndrome. Lancet. 1987 Nov 14;2(8568):1144–1144. doi: 10.1016/s0140-6736(87)91564-9. [DOI] [PubMed] [Google Scholar]
  48. Tremlett M. R., Kelly P. J., Parkins J., Hughes D., Redfern N. Low-dose clonidine infusion during labour. Br J Anaesth. 1999 Aug;83(2):257–261. doi: 10.1093/bja/83.2.257. [DOI] [PubMed] [Google Scholar]
  49. Urban B. J., France R. D., Bissette G., Spielman F. J., Nemeroff C. B. Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity in chronic pain patients. Pain. 1988 May;33(2):169–172. doi: 10.1016/0304-3959(88)90087-5. [DOI] [PubMed] [Google Scholar]
  50. ter Riet G., de Craen A. J., de Boer A., Kessels A. G. Is placebo analgesia mediated by endogenous opioids? A systematic review. Pain. 1998 Jun;76(3):273–275. doi: 10.1016/S0304-3959(98)00057-8. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES